Target Name: ZNF823
NCBI ID: G55552
Review Report on ZNF823 Target / Biomarker Content of Review Report on ZNF823 Target / Biomarker
ZNF823
Other Name(s): Zinc finger protein 823 (isoform 1) | zinc finger protein ZFP-36 | ZN823_HUMAN | zinc finger protein 823 | Zinc finger protein ZFP-36 | Zinc finger protein 823 | ZFP-36 for a zinc finger protein | ZFP 36 for a zinc finger protein | ZNF823 variant 1 | Zinc finger protein 823, transcript variant 1 | HSZFP36

ZNF823: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease are some of the most common and debilitating conditions affecting human beings. These conditions are characterized by progressive loss of brain cells and an inability to replace them, leading to a decline in cognitive function and quality of life. There is currently no cure for these diseases, and existing treatments are only able to provide temporary relief of symptoms. Therefore, the discovery of new drug targets and biomarkers for these diseases is of great importance.

ZNF823: A Potential Drug Target and Biomarker

ZNF823 is a zinc finger protein 823 (isoform 1) that has been identified as a potential drug target and biomarker for neurodegenerative diseases. ZNF823 is a protein that is expressed in various tissues and cells of the body, including the brain. It is known for its role in the development and progression of neurodegenerative diseases, and for its potential as a drug target.

The Importance of ZNF823 as a Drug Target

ZNF823 has been shown to play a role in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. These conditions are characterized by the progressive loss of brain cells, which is thought to be caused by the build-up of abnormal proteins in the brain. ZNF823 has been shown to be involved in the production of these abnormal proteins, and in the regulation of the immune response.

ZNF823 has also been shown to interact with several other proteins that are involved in the development and progression of neurodegenerative diseases. For example, it has been shown to interact with the protein PDGFB, which is a key regulator of cell growth and differentiation. ZNF823 has also been shown to interact with the protein Tau, which is involved in the formation of beta-sheet tangles in the brain and is thought to contribute to the development of neurodegenerative diseases.

The Potential of ZNF823 as a Biomarker

In addition to its potential as a drug target, ZNF823 has also been shown to be a potential biomarker for neurodegenerative diseases. The build-up of abnormal proteins in the brain is a key indicator of the development and progression of neurodegenerative diseases. Therefore, ZNF823 may be used as a biomarker for these conditions.

Studies have shown that ZNF823 levels are affected by the development and progression of neurodegenerative diseases. For example, researchers have shown that levels of ZNF823 are decreased in the brains of people with Alzheimer's disease, and that these levels are correlated with the severity of the disease. Similarly, researchers have shown that levels of ZNF823 are increased in the brains of people with Parkinson's disease, and that these levels are correlated with the severity of the disease.

In addition to its potential as a biomarker, ZNF823 may also be used as a therapeutic target for neurodegenerative diseases. By blocking the activity of ZNF823, researchers may be able to reduce the production of abnormal proteins and improve the function of brain cells. This could lead to improved cognitive function and quality of life in people with neurodegenerative diseases.

Conclusion

ZNF823 is a zinc finger protein 823 (isoform 1) that has been identified as a potential drug target and biomarker for neurodegenerative diseases. ZNF823 is involved in the

Protein Name: Zinc Finger Protein 823

Functions: May be involved in transcriptional regulation

The "ZNF823 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF823 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835 | ZNF836 | ZNF837 | ZNF839 | ZNF839P1 | ZNF84 | ZNF840P | ZNF841 | ZNF843 | ZNF844 | ZNF845 | ZNF846 | ZNF85 | ZNF850 | ZNF852 | ZNF853 | ZNF860 | ZNF862 | ZNF865 | ZNF875 | ZNF876P | ZNF878 | ZNF879 | ZNF880 | ZNF883 | ZNF887P | ZNF888 | ZNF890P | ZNF891 | ZNF90 | ZNF91 | ZNF92 | ZNF93 | ZNF962P | ZNF98 | ZNF99 | ZNFX1 | ZNG1A | ZNG1B | ZNG1C | ZNG1E | ZNG1F | ZNHIT1 | ZNHIT2 | ZNHIT3 | ZNHIT6 | ZNRD2 | ZNRD2-DT | ZNRF1 | ZNRF2 | ZNRF2P1 | ZNRF3 | ZNRF3-AS1 | ZNRF4 | ZP1 | ZP2 | ZP3 | ZP4 | ZPBP | ZPBP2 | ZPLD1 | ZPLD2P | ZPR1 | ZRANB1 | ZRANB2 | ZRANB2-AS1 | ZRANB2-DT | ZRANB3 | ZRS | ZRSR2 | ZRSR2P1 | ZSCAN1 | ZSCAN10 | ZSCAN12 | ZSCAN12P1 | ZSCAN16 | ZSCAN16-AS1 | ZSCAN18 | ZSCAN2 | ZSCAN20 | ZSCAN21 | ZSCAN22 | ZSCAN23 | ZSCAN25 | ZSCAN26 | ZSCAN29 | ZSCAN30 | ZSCAN31 | ZSCAN32 | ZSCAN4 | ZSCAN5A | ZSCAN5B | ZSCAN5DP